Category Archives: Health

What is new in the field of Health. Trending topics, and cutting edge research in the are of Health. Press Releases that give us updates on Health.

Health: Mental Health

Workit Health Awarded Social Determinants NIDA Contract to Expand Development of Data-Driven Digital Addiction Treatment Program

Leave a comment


video-visit-workit-health

Workit Health offers telehealth addiction treatment.

Thousands of Workit members trust our technology to access expert addiction care when they need it, and the NIDA contract allows us to offer intervention before high-risk, high-cost events through machine learning.


ANN ARBOR, Mich. (PRWEB)

Workit Health, the nation’s leading provider of evidence-based telemedicine addiction care, today announced the receipt of a National Institute on Drug Abuse (NIDA) contract to leverage health IT solutions to solve for social determinants of health in addiction care.

This Phase I contract expands the predictive analytics within Workit Health’s addiction-specific electronic medical record platform. Clinicians will access an all-in-one resource for roadmapping social determinants of health, non-medical considerations, and barriers, as well as traditional medical histories and diagnoses. Workit’s proprietary algorithms will provide clinicians a clearer 360 degree view of each patient, improving medication adherence and decreasing frequency of crisis events.

“NIDA’s support of Workit Health solidifies digital care as an alternative to traditional, outdated treatment models,” said Lisa McLaughlin, Workit Health’s Co-CEO. “This allows us to focus on our ability to provide real support for stable housing and transportation through collaborative care teams via telemedicine — we’re able to be there when no one else can.”

“Over 20 million Americans will face addiction in their lifetimes,” said Robin McIntosh, Workit Health’s Co-CEO. “Thousands of Workit members trust our technology to access expert addiction care when they need it, and the NIDA contract allows us to offer intervention before high-risk, high-cost events through machine learning.”

This year, Workit Health was also named a finalist in the BlueCross BlueShield Data Innovation Challenge, receiving access to a subset of Blue Health Intelligence’s national dataset in order to uncover more holistic and comprehensive ways to measure the success of addiction treatments to support the identification, prediction, and prioritization of members and providers for real-time interventions. In 2017, Workit was awarded a grant by the National Science Foundation to develop a “thrive-meter” which assists individuals in identifying success in addiction recovery.

About Workit Health: Workit Health is an addiction healthcare B-corporation offering online, on-demand evidence-based addiction treatment including telehealth medication for opioid use disorder. Workit Health partners with healthcare organizations to deliver an innovative digital health solution that blends the best of human-centered design, technology, and science. Through mobile and web apps, members meet with clinicians and Master’s level coaches and complete self-set recovery goals. Workit Health offers 24/7 recovery that fits into daily life, designed by experts. Learn more at workithealth.com.

Share article on social media or email:

Health

Hoggan Scientific Participant at 2nd Annual Reconstructive Neurosurgery Course

Leave a comment


News Image


SALT LAKE CITY (PRWEB)

Hoggan Scientific, LLC, is a recognized leader in the design and manufacture of medical and ergonomic testing equipment. The company exhibited at the 2nd Annual Reconstructive Neurosurgery Course, with the microFET2 digital handheld dynamometer for muscle testing shown to expert surgeons and physicians from around the world. The product was demonstrated how it is used and be incorporated as part of evaluations for their patients. The microFET2 was well received by the attendees, and were excited to learn how it can be an effective tool to objectively quantify and document muscle strength of patients and track improvement.

Strength measurements are imperative in clinical assessments of a patient’s status and progress over time. Handheld dynamometry has been shown to be a reliable and informative method to measure strength status and changes, compared to other methods such as manual muscle testing. microFET2 is accurate, portable, easy to use, and provides healthcare professionals with a solution that gives precise and objective strength measures for outcome assessments of their patients.

Hoggan Scientific products are used in hospitals, physical and occupational therapy clinics, sports and athletic training facilities, and universities worldwide. For more information about microFET2 and the rest of the microFET product line that Hoggan Scientific offers, please visit the website at http://www.hogganscientific.com, contact by phone at 800-678-7888/801-572-6500, or email at sales@hogganscientific.com. The manufacturer can also be found on Facebook at http://www.facebook.com/HogganScientific.

Share article on social media or email:

Health

Pratia Teams with VirTrial to Become First ‘Virtual Trial Capable’ Site Network in Europe

Leave a comment


News Image

Our network is expanding across Europe and we plan to maintain our 100% Virtual Trial Capable status with VirTrial to best serve our patients and pharma sponsors.


SCOTTSDALE, Ariz. (PRWEB)

VirTrial today announced an alliance with Pratia, the largest network of clinical research centers in Europe. All Pratia research centers have completed VirTrial’s Virtual Trial Capable training, making them the first site network in Europe to become trained and certified as Virtual Trial Capable and prepared to conduct decentralized clinical trials (DCT).

The training program includes four modules that clinical research professionals complete to demonstrate a level of competence in general telemedicine etiquette and guidelines, as well as how to utilize the VirTrial platform. Participants then receive a Virtual Trial Capable certificate and badge to highlight to sponsors and CROs that they are prepared to conduct hybrid decentralized clinical trials.

“Pratia’s mission is to facilitate access to healthcare to improve the quality of life and the sense of security of our patients. Embracing telehealth technologies that enable a larger patient population to participate supports our goal and we’re proud to be the first network in Europe to offer this benefit to sponsors,” said Małgorzata Gerjatowicz-Osmańska, Managing Director of Pratia. “Our network is expanding across Europe and we plan to maintain our 100% Virtual Trial Capable status with VirTrial to best serve our patients and pharma sponsors.”

Amanda Rangel, VP of Business Development for VirTrial, remarked “VirTrial is honored to collaborate with forward-thinking sites like those in the Pratia network that are taking action to move the industry forward and improve patient access to clinical trials. The innovative VirTrial telehealth platform was developed by clinical research professionals and we are committed to continued collaboration with sites and supporting site sustainability in the new era of hybrid decentralized trials.”

For more information on the Virtual Trial Capable certificate program and to access the training modules, go to https://virtrial.com/research-sites/.

About VirTrial

VirTrial is a technology company using a stable, long-standing telehealth platform to transform the clinical trials industry. The platform offers a Virtual Care Management (VCM) program that combines video, text, and email allowing pharmaceutical companies and CROs to create patient-centric trials by replacing some study visits with virtual visits. The vision is for 25-50% of the visits to be conducted virtually creating a hybrid model. This model is ideally suited for Phase III/Phase IV trials where patient compliance can be assessed from any location. Our Virtual Care Management (VCM) program allows sites to review and assess patient compliance. The VirTrial app is supported on any device (Apple, Android, tablet and/or computer) and can be used by any site. It is hosted in a secure, cloud-based, environment and is HIPAA compliant.

VirTrial enables greater accessibility to trials for patients, higher performance by clinical trial sites, and improved outcomes for pharmaceutical companies. Working together we can bring better medications to market more quickly. To learn more about VirTrial, visit https://www.virtrial.com

About Pratia

Pratia was established in 2012 in Poland and has since grown steadily by unifying the best research sites in Europe. In 2014 Pratia joined the NEUCA Capital Group, which underpinned the financial stability and secured the vision of a long-term and sustainable company. Over the years Pratia has built the value of a truly aligned, patient-centric organization, which is well prepared to address the requirements of a dynamically changing clinical research environment including remote monitoring and virtual trial readiness. Pratia intends to ensure that every patient has access to the best clinical therapies by combining patients with doctors using technology. We believe that by building a patient-centric approach, our company will refine clinical trials and lead to great success. To learn more about Pratia, visit https://www.Pratia.com.

Share article on social media or email:

Industry: Healthcare

Dr. Dale Spencer Spreads Gum Disease Awareness to Newton, NC

Leave a comment


Dr. Dale Spencer of Hickory Dental Care, Serving Hickory, NC

Dr. Dale Spencer Raises Awareness of Gum Disease Symptoms in Newton, NC

The mission of the practice is to serve our patients, to help them have better dental health, to feel better about themselves and to do it in a caring, safe manner. That’s pretty much what we are all about.


Newton, NC (PRWEB)

To spread awareness of the importance of gum disease treatment and prevention, Dr. Dale Spencer of Hickory Dental Care invites patients with gum disease in Newton, NC to visit his practice and learn how to improve gum health.

According to a study by the Journal of Dental Research, almost half of Americans over the age of 30 have gum disease. Gum disease typically goes unnoticed, but as it progresses, it breaks down tissues beneath the gum line and can eventually lead to tooth loss. Additionally, gum disease has been linked to systemic health conditions such as diabetes, heart disease, stroke, and premature births.

Gingivitis, the first stage of gum disease, results in red, swollen gums, bleeding gums while brushing and flossing, and chronic bad breath. As gum disease advances into periodontitis and advanced periodontitis, pockets form between the teeth and gums, gums recede, connective tissue deteriorates, and eventually, patients suffer tooth and bone loss.

An expert in gum disease and its consequences, Dr. Spencer realizes the lack of mainstream knowledge about these long-term effects. As a result, he is striving to educate Newton, NC and the surrounding areas on how to recognize gum disease and promote gum health.

“The mission of the practice is to serve our patients, to help them have better dental health, to feel better about themselves and to do it in a caring, safe manner,” Dr. Spencer explains. “That’s pretty much what we are all about.”

To help patients treat gum disease, Dr. Spencer and offers multiple treatment options depending on the severity of the gum disease. These treatments include scaling and root planing, soft tissue recontouring, gum grafting, osseous surgery, and minimally invasive laser gum therapy. His laser gum therapy targets bacteria and diseased tissue without incisions, providing less pain and faster healing time for patients. Dr. Spencer also offers sedation dentistry for patients suffering with dental anxiety.

Patients in Newton, NC with swollen and bleeding gums are encouraged to connect with Dr. Spencer by calling 828-270-7853 or visiting http://www.hickorydental.com. Other services provided at Hickory Dental Care include general dentistry, dental implants, sleep apnea treatment, and cosmetic dentistry.

About the Dentist

Hickory Dental Care offers modern, comprehensive dental care to patients in Hickory, NC, including general dentistry, dental implants, sedation treatment and cosmetic dentistry. Dr. Dale Spencer is a graduate of the University of North Carolina at Chapel Hill, a Fellow of the American Academy of Implant Dentistry and a Diplomate of the American Board of Oral Implantology/Implant Dentistry. He is trained in the latest dental technology and offers comprehensive, comfortable, and predicable treatments for patients, including implant dentistry and IV sedation. The Hickory Dental Care team is dedicated to providing exceptional care for their patients and strives to create an office environment that is welcoming, compassionate, and of the highest quality. To learn more about Dr. Spencer and the services offered at Hickory Dental Care, call 828-270-7853 or visit http://www.hickorydental.com to schedule a consultation.

Share article on social media or email:

Health

Shady Grove Fertility (SGF) New York is Expanding, Welcoming Newest Board Certified Reproductive Endocrinologist, Anate Brauer, M.D., as IVF Director

Leave a comment


https://www.prweb.com/

Anate Brauer, M.D., IVF Director

“Dr. Brauer has a great bedside manner. She is always on time and she explains each step and lays out all of the options available. She seems to really focus on individualized care and not just applying the status quo.” Dr. Brauer patient


NEW YORK (PRWEB)

Shady Grove Fertility (SGF), a practice whose latest expansion brought them to New York, announced today the newest addition of its New York medical team, Anate Brauer, M.D., IVF Director.

Dr. Brauer will join colleague Tomer Singer, M.D., M.B.A. in seeing patients at SGF’s flagship New York office located in the heart of Manhattan, starting in November 2019. Dr. Brauer will offer a full range of state-of-the-art in-house diagnostic and treatment options for female and male infertility, elective fertility preservation, fertility preservation prior to cancer treatment, third-party reproduction, and LGBTQ family building.

Dr. Brauer earned her medical degree from the George Washington University School of Medicine, where she was elected to the prestigious Alpha Omega Alpha medical honor society. She completed her residency in Obstetrics and Gynecology at New York Presbyterian Hospital-Weill Cornell Medical Center. Dr. Brauer subsequently completed her fellowship training in Reproductive Endocrinology and Infertility at the Ronald O. Perelman and Claudia Cohen Center for Reproductive Medicine and Infertility-Weill Cornell Medical College. Prior to joining Shady Grove Fertility, Dr. Brauer was an Assistant Clinical Professor at NYU School of Medicine.

Dr. Brauer is board certified in obstetrics and gynecology and reproductive endocrinology and infertility. She has expertise in ovulation induction, in vitro fertilization (IVF), egg freezing, pre-implantation genetic testing and third-party reproduction including donor egg, donor sperm, donor embryo, and gestational surrogacy. Dr. Brauer applies the latest clinical data, state-of-the-art technology, and extensive clinical experience to optimize pregnancy rates while minimizing patient stress with her supportive approach to care.

Dr. Brauer has published and presented at numerous national meetings on the topics of optimizing fertility treatments in patients with diminished ovarian reserve, polycystic ovarian syndrome (PCOS), or those using a gestational carrier; fertility preservation; and complementary therapies in infertility. She is especially passionate about helping young patients with cancer build families, which has led her to serve on the Advisory Board of the Young Survivors Coalition.

Dr. Brauer is a regular contributor on a variety of women’s health topics to local and national media such as Parents, Reader’s Digest, Refinery 29, Woman’s Health Magazine, Byrdie and Shape, to name a few. For Shape, she serves on their expert Brain Trust.

She is a fellow of the American Congress of Obstetrics and Gynecology and an active member of the American Society for Reproductive Medicine and the Fertility Preservation Special Interest Group.

“We’re delighted to be able to offer patients of greater New York access to Dr. Singer and now Dr. Brauer. Dr. Brauer offers her patients the very best in personalized care. She’s known for her warmth as well as her brilliance, and we’re thrilled to welcome her to the SGF medical team,” remarked Mark Segal, Chief Executive Officer of SGF.

“I’m thrilled with the opportunity to join SGF. Everything we do is based on what’s best for the patient, and that aligns exactly with my patient care philosophy. We believe in transparency, professionalism, and good communication. I’m here to listen, understand, and help my patients overcome the obstacles in front of them by formulating a game plan that helps them regain control over their struggle,” adds Dr. Brauer.

“I chose this particular field of study, in part, because optimism is the key ingredient to success. This field allows me to mix my love of medicine and surgery. Most importantly, my position allows me to help people build the most sought treasure on earth—a family,” adds Brauer.

“I really felt that Dr. Brauer was personally invested in getting me pregnant. She hugged me before the retrieval and again after the positive pregnancy test. She shared details of her own story that put me at ease and allayed my fears. We had a very straight forward and successful IVF, but her upbeat attitude told me that even if we had a setback she’d have a plan b and another path to success,” shared a recent Dr. Brauer patient.

“New York City is an area that’s actually been underserved when it comes to quality, affordable fertility treatment. By offering SGF’s exclusive 100% refund program for IVF and donor egg in NY—which guarantees patients will take home a baby or receive their money back—individuals and couples no longer have to weigh risk versus benefit when trying to start a family. We believe cost should not be a barrier to seeking help from a fertility specialist,” adds Segal.

Dr. Brauer is accepting new patient appointments in SGF’s brand new 15,300 square foot space in New York City, conveniently located at 110 East 60th Street—minutes from nine NY subway stations with easy access from all boroughs as well as Westchester, Long Island, and Connecticut, and steps from Bloomingdales, Rockefeller Center, Central Park, and The Plaza Hotel.

To make an appointment with Dr. Brauer, call 212-203-4826 or submit this brief form.

To schedule an appointment at any of SGF’s other 35 domestic locations, call the SGF New Patient Center at 888-761-1967.

About Shady Grove Fertility (SGF)

SGF is a leading fertility and IVF center of excellence with more than 85,000 babies born and counting. With 36 locations throughout FL, GA, MD, NY, PA, VA, D.C., and Santiago, Chile, we offer patients individualized care, accept most insurance plans, and make treatment affordable through innovative financial options, including treatment guarantees. More physicians refer their patients to SGF than any other center. Call 1-888-761-1967 or visit ShadyGroveFertility.com.

Industry: Healthcare

VirTrial Awarded FDA-Approved Decentralized Clinical Trial with Hope Biosciences

Leave a comment


News Image

Together, we are able to safely deliver and monitor our therapies for patients in the comfort of their homes. What this means for the world of cell therapy is nothing short of groundbreaking!


SCOTTSDALE, Ariz. (PRWEB)

VirTrial has been awarded an FDA-approved hybrid decentralized clinical trial (DCT) with Hope Biosciences. The study provides Hope Biosciences’ autologous, adipose-derived culture-expanded mesenchymal stem cells (HB-adMSC’s) for the treatment of spinal cord injury/disorder (SCI/D). Study protocol incorporates remote visits via VirTrial’s telehealth platform.

“After reviewing countless vendors, we found that VirTrial met our needs as a sponsor and most importantly, patient needs. VirTrial’s partnership in our trial has opened doors for patients who would otherwise be unable to participate due to health and lack of mobility,” stated Donna Chang, President and CEO of Hope Biosciences. “Together, we are able to safely deliver and monitor our therapies for patients in the comfort of their homes. What this means for the world of cell therapy is nothing short of groundbreaking!”

A hybrid decentralized clinical trial eliminates barriers to participation for SCI/D patients who have limited access to travel or suffer from the physical toll travel takes on them. Remote visits limit the demand for all visits to be done in-person. At each remote visit, a registered nurse visits the patient in their home and in conjunction with the physician, who is connected via the telehealth platform, conducts a physical exam. Once the physician gives the approval, the RN can administer the stem cell infusion to the patient in their home.

Mark Hanley, CEO of VirTrial, stated, “VirTrial’s telehealth platform reduces the burden associated with patient participation and makes it possible to recruit patients from a larger geographic area. I applaud progressive sponsors like Hope Biosciences who are embracing virtual trial technology to better serve the patient population and advance the clinical trials industry as a whole.”

Sherry Diers, RN, Clinical Affairs Specialist, Hope Biosciences commented, “The logistics and the physical toll for patients can be substantial. Using the VirTrial platform makes it possible for Hope to reach across hundreds of miles and deliver treatment.”

For more information on VirTrial’s offerings for pharmaceutical sponsors, go to https://virtrial.com/pharmaceuticals

About VirTrial

VirTrial is a technology company using a stable, long-standing telehealth platform to transform the clinical trials industry. The platform offers a Virtual Care Management (VCM) program that combines video, text, and email allowing pharmaceutical companies and CROs to create patient centric trials by replacing some study visits with virtual visits. The vision is for 25-50% of the visits to be conducted virtually creating a hybrid model. This model is ideally suited for Phase III/Phase IV trials where patient compliance can be assessed from any location. Our Virtual Care Management (VCM) program allows sites to review and assess patient compliance. The VirTrial app is supported on any device (Apple, Android, tablet and/or computer) and can be used by any site. It is hosted in a secure, cloud-based, environment and is HIPAA compliant.

VirTrial enables greater accessibility to trials for patients, higher performance by clinical trial sites, and improved outcomes for pharmaceutical companies. Working together we can bring better medications to market more quickly. To learn more about VirTrial, visit https://www.virtrial.com

About Hope Biosciences

Hope Biosciences is a clinical stage biotechnology company focused on developing novel cell-based therapeutics for acute and chronic injury and disease. Hope Bio’s core technology lies in stem cell culture and banking. Mesenchymal stem cells are isolated from approximately one tablespoon of a patient’s own fat tissue, purified, and cultured with Hope Bio’s proprietary culture media, HB-101. HB-adMSCs are expanded to multiple passages and released at Passage 4 for therapeutic use. Samples of each passage are banked in order to create a master cell bank for each patient, which will be used to make additional therapies in the future. HB-adMSCs have already been used as a safe and effective treatment in a Phase I/IIa clinical trial for Rheumatoid Arthritis and Individual Expanded Access IND for Parkinson’s disease, Cerebral Palsy, Spinal Cord Injury and Thrombotic Thrombocytopenic Purpura. To learn more about HOPE Biosciences, visit https://www.hope.bio

Share article on social media or email:

Health

Prominent Cardiologist Dr. Apurva Shah Receives Castle Connolly’s 2019 Top Doctor® Award for the Seventh Consecutive Year

Leave a comment


News Image

It is always an honor to be recognized by my peers. Being included on a list with so many talented physicians as a 2019 Castle Connolly Top Doctor, is quite the compliment. I will continue my commitment to improving the health and well-being of my patients, says Dr. Apurva Shah


ATLANTA (PRWEB)

Dr. Apurva Shah has once again been recognized as a 2019 Castle Connolly Top Doctor. Recipients of this award were nominated by their fellow doctors, and it is a highly selective list. Those who are among the very best in their specialties are chosen for inclusion. Dr. Shah is board-certified in cardiology. Currently, he is a physician at Northside Heart, which is one of North Atlanta’s largest groups providing cardiology services, with multiple locations throughout the area. Practicing primarily out of the Woodstock office, Dr. Shah specializes in cardiovascular diseases and in non-invasive cardiology. He has a particular interest in cardiovascular imaging, including cardiac perfusion studies, echocardiography and cardiac CT. Dr. Apurva Shah is a trusted physician who is dedicated to providing his patients with top-quality medical care. Many of Dr. Shah’s highly-satisfied patients have shared that he is an excellent communicator, attentive and exceptionally knowledgeable in his field.

“It is always an honor to be recognized by my peers. Being included on a list with so many talented physicians as a 2019 Castle Connolly Top Doctor, is quite the compliment. I will continue my commitment to improving the health and well-being of my patients,” says Dr. Apurva Shah

About Castle Connolly and America’s Top Doctors ®

The mission of Castle Connolly Medical Ltd. is to help consumers find the best healthcare. The top doctors who are listed on their books and website directory were nominated by peers in an extensive survey process of thousands of American doctors each year. These Top Doctors’ medical educations, training, hospital appointments and disciplinary histories are rigorously screened by the Castle Connolly physician-led research team. Doctors do not and cannot pay to be included in any Castle Connolly Guide or online directory.

More about Dr. Apurva Shah

Dr. Shah has been practicing medicine for the past twenty years. He completed his medical school training at the Chicago Medical School and his internal medicine residency at Thomas Jefferson University Hospital in Philadelphia, PA. His cardiology fellowship was performed at the University of Medicine and Dentistry/Robert Wood Johnson Medical School of New Jersey. During that training, he also spent time at the Deborah Heart and Lung Transplant Center. He has been practicing medicine in the Atlanta, Georgia area since 2005.

To schedule an appointment or learn more about Dr. Apurva Shah and Northside Heart please call 770-924-5095 or visit http://www.northsideheart.com/physician/apurva-shah. His Top Doctor profile may also be reviewed on http://www.castleconnolly.com.

Share article on social media or email:

Industry: Healthcare

RealTime Software Solutions Announces They Have Joined SCRS Global Impact Partner Program

Leave a comment


The GIP program gives us the opportunity to listen and contribute on a whole new level


SAN ANTONIO (PRWEB)

As a dedicated leader in the clinical trial industry, RealTime Software Solutions is pleased to announce that they have joined the Society for Clinical Research Sites Global Impact Partner (GIP) Program.

RealTime CEO Rick Greenfield, a long-time member of SCRS, says the partnership is just another way for the company to come together with industry leaders to help streamline the way research is done.

“As a long-time attendee of the Site Solutions Summit and proud member of SCRS, I have seen first-hand the difference that SCRS has made for clinical research sites and the research industry as a whole,” says Greenfield. “I could not be prouder to bring RealTime into the GIP family at SCRS and to join the cause for better processes, systems and best practices that will improve the clinical research landscape for Sites, CROs and Sponsors alike. At RealTime, we prioritize the needs of the industry so we can offer solutions that truly make a difference. The GIP program gives us the opportunity to listen and contribute on a whole new level.”

As a member of GIP, RealTime will have the opportunity to work directly with major players in all facets of the clinical research industry to include large-scale CROs, data vendors, service providers, sites and site networks that all have a hand in shaping clinical research.

Members also benefit by having a seat on the GIP board which interfaces with SCRS leadership to set strategic initiatives for the Society. SCRS GIP members may also elect to engage the SCRS community for individual corporate objectives using SCRS program options that include focus groups, surveys, research, content development, and geographic or regional site support.

To learn more about RealTime Software Solutions, visit RealTime-CTMS.com.

About RealTime Software Solutions

Founded in February of 2013, RealTime Software Solutions, LLC strives to bring innovative Clinical Trial Management Systems (CTMS) to sites, CROs and sponsors of all shapes and sizes. The core values of RealTime include, “Innovation Now”, “Think Like Customers” and “Integrity Always”. These values have helped RealTime grow into a leading CTMS provider for systems like SitePAY, GlobalPAY, eDOCS and eSOURCE for thousands of customers around the world. RealTime will continue the pursuit of advanced systems and processes that enhance the workflow and efficiency of all stakeholders within the clinical research execution process. Visit RealTime-CTMS.com to learn more.

Share article on social media or email:

Health

ImPACT Applications Successfully Meets Standards of the Medical Device Single Audit Program (MDSAP)

Leave a comment


“Passing the MDSAP is a major accomplishment and yet another example of ImPACT Applications, Inc.’s commitment to quality and compliance.”


SAN DIEGO (PRWEB)

ImPACT Applications successfully passes the intensive Medical Device Single Audit Program (MDSAP) and obtains ISO 13485 re-certification. The audit requires full transparency with the quality management system structure, corrective action and preventive action, software development lifecycle, and IT infrastructure to ensure the public’s security and privacy.

“Choosing to participate in the MDSAP wasn’t a question for us,” said Michael Zagorski, ImPACT Applications’ Director of Regulatory Affairs and Privacy Officer. “Everything from our company procedures to staff training and privacy practices is geared towards making products people can trust.”

MDSAP was created with the goal to unify medical device audit standards to improve their safety and oversight on a global scale. As a worldwide leader in concussion management software, ImPACT Applications is well-equipped to address evolving regulatory agencies’ standards.

Along with being regulatory compliant, ImPACT Applications’ products have over 500 plus research articles (https://concussionresearch.com/) containing independent and peer-reviewed studies that help healthcare providers validate the use of their concussion assessment tools.

“Passing the MDSAP is a major accomplishment and yet another example of ImPACT Applications, Inc.’s commitment to quality and compliance,” said Michael Wahlster, ImPACT Applications’ Chief Executive Officer. “This multi-country audit is necessary for an industry that sees rapid innovation and will help ensure medical device companies prioritize public safety.”

About ImPACT Applications:

ImPACT Applications, Inc. is the maker of ImPACT®, ImPACT Pediatric®, and ImPACT Quick Test®, all FDA cleared Class I & II medical devices that assist in the assessment and management of concussion. ImPACT Applications also offers the FDA cleared ImPACT Baseline Test to home-based users worldwide.

ImPACT Applications products are used by most major medical centers, professional sports leagues and teams, colleges, high schools, and select military units. Since 2002, ImPACT Applications has administered more than 18 million tests to over 11 million users. For more information, visit https://impacttest.com/.

Share article on social media or email:

Industry: Healthcare

The first International Sigma Anti-Bonding Calcium Symposium (ISACS 2019) by CBHI

Leave a comment


https://www.prweb.com/

ISACS 2019

I hope more people be aware of the importance of bone health and the available solutions for their bodies.


VANCOUVER, British Columbia (PRWEB)

Calcium & Bone Health Institute (CBHI) held International Sigma Anti-Bonding Calcium Symposium (ISACS) 2019 at Executive Plaza Hotel in Vancouver, Canada on September 23-24 for two days. The purpose of symposium was to discuss and share the knowledge of the various measures to develop healthy bone and to prevent calcium-related diseases. The theme of this year was “The Secret of Reversible Bone Health”.

“While serving as the president of CBHI which conducts intensive research about the significance of calcium for the human body, I thought of a place where researchers and professors come together to share their knowledge and create synergy effect in their research field,” said Dr. Paul Lee, the ISACS Chair. “I am very grateful that we could start the first Symposium in Vancouver, Canada. I hope more people be aware of the importance of bone health and the available solutions for their bodies.”

The speakers included researchers, professors, dentists, pharmacists, businessmen and patients. People from U.S.A., Canada, Korea, China, Indonesia, and Japan attended in the event. The topics by speakers ranged from cancer, bone, dental treatment, and arrhythmias, to diabetes. Testimonials by patients with SAC treatment were also presented.

SAC (Sigma Anti-Bonding Calcium) calcium was invented by Dr. Paul Lee in 2009. The atomic orbitals of SAC calcium molecule have sigma anti-bonding and therefore, easily separated into atoms in the water, absorbed in the body in the ionic form, Ca++. It is 200 times more soluble in water and has shown up to 80% bone mineral density increase in thousands of people. SAC calcium awakens body’s dormant response and the process is fully natural without side effect.

As the first ISACS 2019 was successfully held, CBHI plans to hold the event internationally following years.

About CBHI

Calcium and Bone Health Institute (CBHI) is Canada based research organization that has invented Sigma Anti-bonding Calcium (SAC). It has partnership with many universities and research organizations. Its invented SAC calcium was tried by thousands of people with great responses from their bodies. It continues to research on many challenging diseases such as osteoporosis, cancer, stem cell, diabetes, Alzheimer’s disease and more.

Share article on social media or email: